Altered responses to pneumococcal vaccination in an elderly diabetic Japanese vaccine trial: The risk of concurrent vaccination strategies

被引：1
作者：
Norton, Elizabeth B. [1 ]
机构：
[1] Tulane Univ, Sch Med, Dept Microbiol & Immunol, 1430 Tulane Ave 8638, New Orleans, LA 70112 USA
来源：
JOURNAL OF DIABETES AND ITS COMPLICATIONS | 2019年 / 33卷 / 03期
关键词：
POLYSACCHARIDE VACCINE; PNEUMONIA; ADULTS; COMMUNITY; INFLUENZA; SAFETY;
D O I：
10.1016/j.jdiacomp.2018.12.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：189 / 190
页数：2
相关论文
共 41 条
  • [31] Flexibility of Oral Cholera Vaccine Dosing-A Randomized Controlled Trial Measuring Immune Responses Following Alternative Vaccination Schedules in a Cholera Hyper-Endemic Zone
    Kanungo, Suman
    Desai, Sachin N.
    Nandy, Ranjan Kumar
    Bhattacharya, Mihir Kumar
    Kim, Deok Ryun
    Sinha, Anuradha
    Mahapatra, Tanmay
    Yang, Jae Seung
    Lopez, Anna Lena
    Manna, Byomkesh
    Bannerjee, Barnali
    Ali, Mohammad
    Dhingra, Mandeep Singh
    Chandra, Ananga Mohan
    Clemens, John D.
    Sur, Dipika
    Wierzba, Thomas F.
    PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (03):
  • [32] Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH)
    Song, Joon-Young
    Chang, Chih-Jen
    Andrews, Charles
    Diez-Domingo, Javier
    Oh, Myoung-Don
    Dagan, Ron
    Hartzel, Jonathan
    Pedley, Alison
    Li, Jianing
    Sterling, Tina
    Tamms, Gretchen
    Chiarappa, Joseph A.
    Lutkiewicz, Jeannine
    Musey, Luwy
    Tu, Yingmei
    Buchwald, Ulrike K.
    VACCINE, 2021, 39 (43) : 6422 - 6436
  • [33] Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial
    Peikert, Alexander
    Claggett, Brian L.
    Kim, KyungMann
    Udell, Jacob A.
    Joseph, Jacob
    Desai, Akshay S.
    Farkouh, Michael E.
    Hegde, Sheila M.
    Hernandez, Adrian F.
    Bhatt, Deepak L.
    Gaziano, J. Michael
    Talbot, H. Keipp
    Yancy, Clyde
    Anand, Inder
    Mao, Lu
    Cooper, Lawton S.
    Solomon, Scott D.
    Vardeny, Orly
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (02) : 299 - 310
  • [34] Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants
    Murata, Shinya
    Shirakawa, Masayoshi
    Sugawara, Yoshie
    Shuto, Michiko
    Sawata, Miyuki
    Tanaka, Yoshiyuki
    PAPILLOMAVIRUS RESEARCH, 2020, 10
  • [35] Safety and reactogenicity of primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Vietnamese infants: a randomised, controlled trial
    Tran Ngoc Huu
    Nguyen Trong Toan
    Ha Manh Tuan
    Ho Lu Viet
    Pham Le Thanh Binh
    Ta-Wen Yu
    Fakrudeen Shafi
    Ahsan Habib
    Dorota Borys
    BMC Infectious Diseases, 13
  • [36] Safety and reactogenicity of primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine in Vietnamese infants: a randomised, controlled trial
    Tran Ngoc Huu
    Nguyen Trong Toan
    Ha Manh Tuan
    Ho Lu Viet
    Pham Le Thanh Binh
    Yu, Ta-Wen
    Shafi, Fakrudeen
    Habib, Ahsan
    Borys, Dorota
    BMC INFECTIOUS DISEASES, 2013, 13
  • [37] Priming with Japanese encephalitis virus or yellow fever virus vaccination led to the recognition of multiple flaviviruses without boosting antibody responses induced by an inactivated Zika virus vaccine
    Li, Yifan
    Merbah, Melanie
    Wollen-Roberts, Suzanne
    Beckman, Bradley
    Mdluli, Thembi
    Curtis, Daniel J.
    Currier, Jeffrey R.
    Mendez-Rivera, Letzibeth
    Dussupt, Vincent
    Krebs, Shelly J.
    Barrera, Rafael De La
    Michael, Nelson L.
    Paquin-Proulx, Dominic
    Eller, Michael A.
    Koren, Michael A.
    Modjarrad, Kayvon
    Rollanda, Morgane
    EBIOMEDICINE, 2023, 97
  • [38] Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial
    Dicko, Alassane
    Odusanya, Olumuyiwa O.
    Diallo, Abdoulbaki I.
    Santara, Gaoussou
    Barry, Amadou
    Dolo, Amagana
    Diallo, Aminata
    Kuyinu, Yetunde A.
    Kehinde, Omolara A.
    Francois, Nancy
    Borys, Dorota
    Yarzabal, Juan P.
    Moreira, Marta
    Schuerman, Lode
    BMC PUBLIC HEALTH, 2011, 11
  • [39] Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine (PCV13) formulated with 2-phenoxyethanol in multidose vials given with routine vaccination in healthy infants: An open-label randomized controlled trial
    Idoko, Olubukola T.
    Mboizi, Robert B.
    Okoye, Michael
    Laudat, France
    Ceesay, Bubacarr
    Liang, John Z.
    Le Dren-Narayanin, Natacha
    Jansen, Kathrin U.
    Gurtman, Alejandra
    Center, Kimberly J.
    Scott, Daniel A.
    Kampmann, Beate
    Roca, Anna
    VACCINE, 2017, 35 (24) : 3256 - 3263
  • [40] Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine An open-label, randomized trial in Japanese children aged 6 months to 17 years
    Saitoh, Akihiko
    Nagai, Akira
    Tenjinbaru, Kazuyoshi
    Li, Ping
    Vaughn, David W.
    Roman, Francois
    Kato, Tatsuo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (06) : 749 - 758
12345